Nodal Metastasis From Locally Advanced Esophageal Cancer: How Neoadjuvant Therapy Modifies Their Frequency and Distribution
Neoadjuvant chemoradiotherapy (CT-RT) before esophagectomy seems to affect the number of nodal metastasis and to alter the distribution of those that remain. The aim of this study was to define how neoadjuvant chemoradiotherapy changes nodal metastasis patterns in locally advanced esophageal cancer.
A total of 402 consecutive patients with cancer of the esophagus or esophagogastric junction (181 adenocarcinoma [AC] and 221 squamous cell carcinoma [SCC]) (evaluated at clinical stage T1N1, T2N1, T3N0, or T3N1 and pathological stage M0) presenting in our Department between 1992 and 2007 and who underwent complete resection (R0) were included in this retrospective study on a prospectively collected database. All dissected lymph nodes were retrieved and microscopically analyzed. Nodal metastasis patterns in patients who underwent chemotherapy (CT) or chemoradiotherapy (CT-RT) neoadjuvant therapy were compared with those in patients who underwent surgery alone.
Almost 30% of the adenocarcinoma patients and approximately 40% of the SCC patients showed effective tumor downstaging after neoadjuvant therapy. There were fewer paracardial node metastases (P = .002) in the AC patients who underwent CT-RT neoadjuvant therapy. There were, likewise, significantly fewer paraesophageal, paracardial, and subcarinal node metastases in the SCC patients in whom the perigastric nodes became the second-most frequent site of metastasis.
Not only was frequency of lymph node metastases decreased after neoadjuvant therapy, but nodal localization and pattern were also significantly modified.
KeywordsEsophageal Cancer Esophageal Squamous Cell Carcinoma Squamous Cell Carcinoma Patient Advanced Esophageal Cancer Middle Thoracic Esophagus
The authors are extremely grateful to Linda Inverso for her kind help in the revision of the English language and for editing the final version of the paper.
- 21.Sobin L, Wittekind C. UICC: TNM Classification of Malignant Tumors. 6th ed. New York: Wiley, 2002.Google Scholar
- 25.Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer. 2001;91: 2165–74.PubMedCrossRefGoogle Scholar
- 31.Sutton P, Clark P. Neo-adjuvant treatment for oesophageal cancer. GI Cancer. 2000;3:231–8.Google Scholar
- 33.Fumagalli U. Resective surgery for cancer of the thoracic esophagus: results of a consensus conference held at the VIth World Congress of the International Society for Diseases of the Esophagus. Dis Esophagus. 1996;9:S30–S38.Google Scholar